Oceania Healthcare (OCA) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
21 Jun, 2026Offer and investment highlights
Up to $100 million in fixed rate, secured, unsubordinated bonds offered, with potential for $25 million in oversubscriptions, maturing July 2032.
Bonds guaranteed by key group subsidiaries and proceeds to repay bank debt and for general corporate purposes.
Balanced portfolio of aged care and retirement living assets, with a strong balance sheet and clear growth strategy.
Gearing at 30.1%, at the low end of the board's target range, with over $200 million in cash and undrawn facilities.
Dividend paused pending positive operating free cash flow; significant debt reduction achieved.
Business overview and strategy
Operates 30 sites across New Zealand, with 898 care beds, 1,115 premium care suites, 834 villas, and 1,090 apartments.
Three core segments: aged care, retirement living, and development, offering a continuum of care.
Development pipeline of ~1,270 units, with flexibility to adapt to market conditions and staged growth.
Proven development capability, delivering over 1,670 units since 2017 IPO.
Strategic focus on maximising occupancy, increasing premium revenue, and expanding in demand markets.
Financial highlights and performance
Record underlying result for FY26: total comprehensive income of $75.0m, up 0.5% YoY.
Proforma underlying EBITDA exceeded $97.7m, up 20.2% from FY25.
Free cash flow from operations improved 64% to ($15.0m), on track to be positive in FY27.
Net debt reduced by $121m to $507m; gearing decreased to 30.1%.
Total assets increased to $3.1b, with net tangible assets per share up 7.3% to $1.62.
Latest events from Oceania Healthcare
- Comprehensive income up $28.6m, EBITDA up 19%, and gearing reduced to 34.8%.OCA
H1 202616 Jun 2026 - EBITDA up, cash flow strong, but net profit down; sales and debt reduction remain key priorities.OCA
H1 202516 Jun 2026 - EBITDA up 4.1%, sales volumes up 9.2%, and cost savings of up to $20m targeted.OCA
H2 202516 Jun 2026 - Record sales, EBITDA growth, and debt reduction position for positive cash flow in FY27.OCA
H2 202622 May 2026 - Asset and sales growth, no FY25 dividend, and focus on efficiency and sustainability.OCA
AGM 20253 Feb 2026 - Strong financial growth, reinvestment, and innovation shape future strategy.OCA
AGM 20243 Feb 2026 - Disciplined execution and service innovation drive sustainable growth and returns to FY31.OCA
Investor Day 2025 Presentation15 Sep 2025 - Underlying EBITDA rose 4.1% as sales volumes and operational efficiency both improved.OCA
Investor Presentation1 Jul 2025 - Refinancing, sales growth, and divestments drive debt reduction and operational optimisation.OCA
Investor Presentation1 Jul 2025